Note: Event times and speaker lineups are subject to change
This panel will examine the factors contributing to the disparity in pharmaceutical innovation between the USA and Europe, as well as the factors facilitating the construction of excellence clusters in biomedical research. This includes investigating investment climates, regulatory frameworks, and cultural attitudes toward entrepreneurship and risk. The discussion will also explore strategic actions necessary to strengthen the European pharmaceutical industry, addressing challenges and opportunities for collaboration in the global market. Insights from industry leaders will contribute to a deeper understanding of the future of pharmaceutical innovation in Europe.
SPEAKERS: